Start low (1 gram daily) to assess tolerance, then increase gradually if needed
Your provider can interpret your genetic results alongside your metabolic labs, body composition, and symptom response to optimize your protocol and adjust doses evidence-based rather than by chart alone
Clinical Points GLP-1 receptor agonists (GLP-1 RAs), such as exenatide, demonstrated efficacy in reducing heavy drinking days and total alcohol intake in individuals with obesity-related alcohol use disorders, suggesting a potential role for GLP-1 RAs in targeted treatments for alcohol dependency, particularly in patients with specific metabolic profiles
The light stimulus reaches the SCN via the retinohypothalamic tract (RHT) (Fig
It mimics the actions of sermorelin, which increases GH levels and acts on growth hormone-releasing hormone (GHRH) receptors
FAR1/FHY3 transcription factors positively regulate the salt and temperature stress responses in Eucalyptus grandis
